The New York Times Magazine published an article last week about the lesser-discussed ways selective serotonin reuptake inhibitors, such as fluoxetine and paroxetine, which are frequently prescribed to treat depression and anxiety , affect adolescents ‘ sexual development.

Post-SSRI sexual dysfunction is a condition in which sexual side effects from SSRIs (and serotonin and norepinephrine reuptake inhibitors) persist after an individual stops taking the medication . Documented side effects include a loss of sexual desire and arousal, numbness in one’s sexual anatomy, and erectile dysfunction.

Recommended Stories

Trump’s hemp ban is a huge victory for public health

How a Pennsylvania school district tried (and failed) to usurp parental rights

Think screens are bad for child

See Full Page